242 related articles for article (PubMed ID: 28741179)
21. Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates.
Sandoval PJ; Zorn KM; Clark AM; Ekins S; Wright SH
Mol Pharmacol; 2018 Sep; 94(3):1057-1068. PubMed ID: 29884691
[TBL] [Abstract][Full Text] [Related]
22. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.
Murthy S; Born E; Mathur SN; Field FJ
J Lipid Res; 2002 Jul; 43(7):1054-64. PubMed ID: 12091489
[TBL] [Abstract][Full Text] [Related]
23. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
24. Effect of 7-ketocholesterol incorporation on substrate binding affinity and turnover rate of the organic cation transporter 2 (OCT2).
Xiu F; Console L; Indiveri C; Su S; Wang T; Visentin M
Biochem Pharmacol; 2024 Feb; 220():116017. PubMed ID: 38176620
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
[TBL] [Abstract][Full Text] [Related]
27. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells.
Norata GD; Ongari M; Uboldi P; Pellegatta F; Catapano AL
Int J Mol Med; 2005 Oct; 16(4):717-22. PubMed ID: 16142410
[TBL] [Abstract][Full Text] [Related]
28. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
Bełtowski J
Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
[TBL] [Abstract][Full Text] [Related]
29. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
[TBL] [Abstract][Full Text] [Related]
30. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen sulfide accumulates LDL receptor precursor via downregulating PCSK9 in HepG2 cells.
Huang Y; Ning K; Li WW; Lin G; Hou CL; Wang MJ; Zhu YC
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1082-C1096. PubMed ID: 32938225
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
[TBL] [Abstract][Full Text] [Related]
33. Renal organic cation transporters mediated cadmium-induced nephrotoxicity.
Soodvilai S; Nantavishit J; Muanprasat C; Chatsudthipong V
Toxicol Lett; 2011 Jul; 204(1):38-42. PubMed ID: 21513783
[TBL] [Abstract][Full Text] [Related]
34. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
35. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development.
Pinto CL; Kalasekar SM; McCollum CW; Riu A; Jonsson P; Lopez J; Swindell EC; Bouhlatouf A; Balaguer P; Bondesson M; Gustafsson JÅ
Mol Cell Endocrinol; 2016 Jan; 419():29-43. PubMed ID: 26427652
[TBL] [Abstract][Full Text] [Related]
36. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.
Ogihara T; Chuang JC; Vestermark GL; Garmey JC; Ketchum RJ; Huang X; Brayman KL; Thorner MO; Repa JJ; Mirmira RG; Evans-Molina C
J Biol Chem; 2010 Feb; 285(8):5392-404. PubMed ID: 20007976
[TBL] [Abstract][Full Text] [Related]
37. Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity.
Nieskens TTG; Peters JGP; Dabaghie D; Korte D; Jansen K; Van Asbeck AH; Tavraz NN; Friedrich T; Russel FGM; Masereeuw R; Wilmer MJ
Drug Metab Dispos; 2018 May; 46(5):592-599. PubMed ID: 29514829
[TBL] [Abstract][Full Text] [Related]
38. Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.
Noorlander A; Wesseling S; Rietjens IMCM; van Ravenzwaay B
Toxicol Lett; 2021 Jun; 343():34-43. PubMed ID: 33639197
[TBL] [Abstract][Full Text] [Related]
39. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.
ElAli A; Hermann DM
Brain Pathol; 2012 Mar; 22(2):175-87. PubMed ID: 21767321
[TBL] [Abstract][Full Text] [Related]
40. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
